Clinical Trial Update: Immunogenicity and Safety Study of A New Chromatographically Purified Vero Cell Rabies Vaccine With ID Regimen and ERIG [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the immunogenicity and safety of a chromatographically purified Vero cell rabies vaccine given with an intradermal regimen an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Chromatographically Purified Vero Cell Rabies Vaccine (ID regimen) (Rabies vaccine, vero cell)
• Equine Rabies Immunoglobulin (ERIG) (Equine rabies immunoglobulin)

Snippet

Sponsor: Queen Saovabha Memorial Institute | Conditions: Rabies | Phase 4 | Status: COMPLETED